c-LEcta GmbH
Vaishnavi Devarakonda is an experienced sales manager currently working at c-LEcta GmbH since August 2020, with a strong background in life sciences management. Previous roles include a trainee position at ATV GmbH, where responsibilities encompassed pharmaceutical business, market access, and regulatory affairs. As a senior business development executive at Vivo Bio Tech Ltd. and Noki Technologies Pvt Ltd., Vaishnavi excelled in customer relationship management, market analysis, and team training. Vaishnavi holds a Master of Science in Microbiology from Osmania University and has furthered education in relevant fields.
c-LEcta GmbH
c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. It develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. c-LEcta offers DENARASE, agenetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. Marc Struhalla and Thomas Greiner-Stöffele founded it in 2004, with its headquarters in Leipzig in Germany.